Novel antibody 007 targets the elusive HIV envelope epitope
View as a Web Page
News Medical
 
  HIV/AIDS HIV/AIDS logo  
  The latest HIV/AIDS news from News Medical  
 Study reveals previously unknown role for viral protein integrase in HIV's life cycleStudy reveals previously unknown role for viral protein integrase in HIV's life cycle
 
The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.
 
 
 Novel antibody 007 targets the elusive HIV envelope epitopeNovel antibody 007 targets the elusive HIV envelope epitope
 
HIV-1 can be neutralized by antibodies which bind to vulnerable structures on the virus surface. One such vulnerable site is the so-called V3 glycan site of the viral envelope protein.
 
   Researchers uncover vulnerabilities in elusive HIV reservoir clonesResearchers uncover vulnerabilities in elusive HIV reservoir clones
 
A new study has overcome a long-standing challenge-how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure.
 
   T immune cell transcriptomic clock measures aging in specific immune cellsT immune cell transcriptomic clock measures aging in specific immune cells
 
A new research paper was published in Volume 18 of Aging-US on February 8, 2026, titled "Single-cell transcriptomics reveal intrinsic and systemic T cell aging in COVID-19 and HIV."
 
 Bioengineered E. coli bacteria can now produce rhododendron-derived drugs
 
Bioengineered E. coli bacteria can now produce rhododendron-derived drugsBioengineered E. coli bacteria can now produce a group of compounds with anticancer, anti-HIV, antidiabetic and anti-inflammatory activities.
 
 
 Study quantifies the economic implications of living with HIV
 
Study quantifies the economic implications of living with HIVA recent study, published in Nature Communications, shows that in the Netherlands, people who are diagnosed with HIV are less likely to be employed, work fewer hours, earn less income, and are more likely to receive disability benefits up to seven years after diagnosis.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026